Health tech company, Skin Analytics has raised £15 million in Series B funding to increase their product offering and expand overseas into “key markets struggling with dermatologist shortages”.
Led by AI-focused investor, Intrepid Growth Partners, the funding will primarily be used to “launch products that cover all dermatology concerns”. It will also help Skin Analytics to increase their reach to Europe, Australia and the US, with the aim to make their products available globally as a way to tackle the worldwide “scarcity of practitioners” in dermatology.
Their AI medical device, DERM, is reportedly already being used in 26 NHS sites, where it has detected over 14,000 cancers and is said to help in “ruling out the most high risk skin cancers 99.8% of the time”.
Founder and CEO of Skin Analytics, Neil Daly commented on the series of funding: “AI allows us to move from a world of specialist scarcity to one where we have the capacity to see everyone who is concerned about their skin. Starting with skin cancer, this funding allows us to work with our partners to build new models of care that everyone can access, whenever they want to. That brings us closer to the world where no one dies from skin cancer. We have proven this technology in the UK and are now making it available globally.”
Investing in digital transformation across health and care
Last month we reported on healthcare AI company, Heidi raising $16.6m in its latest round of funding, to help with the development of their AI scribe, which is said to automate time-consuming note taking and document generation. The company also announced its ambient AI tech is to be introduced to 53 GP practices, following an agreement with the Modality Partnership, a GP super-partnership.
NHS Greater Glasgow and Clyde recently awarded a £307k contract to the virtual care solution Doccla, for its remote management platform aimed at helping patients with long-term health conditions. The contract covers the installation of the Doccla virtual ward solution, which was chosen for its ability to offer remote support to patients and scalability capabilities which will reportedly help “manage the expansion of patient numbers”.
London and Derby-based digital messaging platform Alertive secured £3.7 million in funding from private investors to drive its UK expansion, announcing plans to “continue breaking down communication barriers within healthcare teams by integrating more third-party systems and enhancing workflows”. The platform is currently being used in 25 hospitals across 15 NHS trusts, with a reported 50,000 users.
